Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Portugal
- Sweden
- France
- Germany
- Australia
- Denmark
- Spain
- Netherlands
- Singapore
- Japan
- United Arab Emirates
- Belgium
- Italy
- Norway
- Ireland
- Canada
- Poland
- Austria
- Finland
- Lithuania
- Morocco
- Switzerland
- Czech
- Romania
- Brazil
- Cyprus
- Guadeloupe
- Saudi Arabia
- Slovenia
- Worldwide
- 22 more »
- « less
-
Program
-
Field
-
prevention and restorative measures To be trained in the infusion center, proficient IV skills a plus. Administration of medications and therapeutic agents vital to implement the treatment, disease prevention
-
the synthesis of phenalenone-based photosensitisers and their coupling to targeting units developed within the consortium. He/she will perform physico-chemical characterization of the photosensitisers, contribute
-
the Virology Unit Director and Manager and RBL/DHVI leadership. Follow Data Management procedures. The successful applicant must be eligible for and willing to: Work with hazardous biological agents handled
-
therapies for vision loss, and evaluate promising therapeutic agents for potential clinical trials. Job Description Primary Duties & Responsibilities: For more information on the Neurofibromatosis Center
-
components are subject to additional approvals based on UC policy. Your placement within the salary range is dependent on a number of factors including your work experience and internal equity within
-
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences | Czech | about 1 month ago
will focus on the rational design and synthesis of tailored chelating agents capable of selectively binding and recovering the corresponding metal ions from complex secondary and low-grade primary
-
for Interference-Based Brain Stimulation. The DC will develop the theoretical foundations and system designs for a self-optimizing and self-healing implanted communication network enabling transcalvarial networked
-
Medicine, Division of Cardiovascular Health & Disease is recruiting a full-time Post Doctoral Fellow to work with Dr. Christy Holland and Dr. Kevin Haworth to develop targeted echogenic agents with
-
extend an offer by April 8, 2026. Selection Process Applications are reviewed, and decisions made, based on each applicant's knowledge, experience, and past teaching record. Preferential consideration will
-
extend an offer by April 8, 2026. Selection Process Applications are reviewed, and decisions made, based on each applicant's knowledge, experience, and past teaching record. Preferential consideration will